Insider Transactions Reported by 17 Insiders of Perspective Therapeutics, Inc.

Symbol
CATX on NYSE
Location
Seattle, WA

Insiders trading volume in the past year

Perspective Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lantheus Alpha Therapy, LLC 10%+ Owner $110,934,724 06 Mar 2024
Lori A. Woods Director $400,989 +$49,999 +14% 31 Mar 2025
Robert F. Williamson III Director $394,522 +$152,097 +63% 12 Nov 2025
Johan M. Spoor Chief Executive Officer, Director $194,133 +$59,673 +44% 28 Mar 2025
Jonathan Hunt Chief Accounting Officer $121,202 +$22,295 +23% 13 Nov 2025
HEIDI HENSON Director $100,004 03 Mar 2025
Juan Graham Chief Financial Officer $79,490 +$74,946 +1649% 28 Mar 2025
Mark Austin VP Finance/Prin Fin&Acct Offic $30,251 17 Jul 2024
Alan Hoffmann Director 21 Jul 2022
Philip J. Vitale Director 21 Jul 2022
William Cavanagh Chief R&D Officer 21 Jul 2022
Joel Sendek Chief Financial Officer 04 Sep 2025
Michael McCormick Director 21 Feb 2023
Frank Morich Director 03 Mar 2025
Jennifer Streeter COO & VP of HR 12 Jun 2023
Markus Puhlmann Chief Medical Officer 03 Mar 2025
Maria E. Martinez Director 03 Sep 2025

Recent Insider Transactions by Companies or Individuals for Perspective Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.